A shareholder benefit program has been introduced since 2024, and the board has resolved to continue it. The standard applies to shareholders recorded on the shareholder register with 100 shares or more as of each record date, and a QUO card worth 2,500 yen is provided per record date.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3750","jir_company_name":"ADR Biomedic al Holdings Limited","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-08-25","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/3750-20260825-01.pdf","jir_short_summary":"A shareholder benefit program has been introduced since 2024, and the board has resolved to continue it. The standard applies to shareholders recorded on the shareholder register with 100 shares or more as of each record date, and a QUO card worth 2,500 yen is provided per record date.","jir_summary":"### Overview of the Shareholder Benefit Program\nADR Biomedic al Holdings Limited introduced a shareholder benefit program in 2024. The program provides the benefit twice a year on the record dates of the end of September and the end of March, targeting shareholders who hold 100 shares or more as of the record date. The benefit is QUO card valued at 2,500 yen per record date.\n\n### Continuation Resolution and Eligible Shareholders\nAt today's board meeting, the continuation of the shareholder benefit program was resolved. The program aims to reward shareholders and to encourage long-term holding. Eligible shareholders are those holding 100 shares or more as of each record date, with entries as of the end of September and the end of March applying.","jir_financial_highlights":"Unknown: Unknown (Unknown)","jir_category":"","jir_hashtags":"#ADRBiomedic al Holdings Limited, #ContinuationOfShareholderBenefits","jir_key_figures":"Shareholder benefit: QUO card 2,500 yen per record date\nRecord dates: End of September, End of March\nEligible shareholders: holders of 100 shares or more","jir_meta_title":"[ADR Biomed ic al Holdings Limited] Notice of Continuation of Shareholder Benefit Program | August 2026","jir_meta_description":"ADR Biomed ic al Holdings Limited will continue the shareholder benefit program. Record dates are the end of September and end of March; eligible shareholders are those holding 100 shares or more, with a QUO card worth 2,500 yen provided per record date.","jir_og_title":"ADR Biomedic al Holdings Limited \u2014 Notice of Continuation of Shareholder Benefit Program","jir_og_description":"Continuation of the shareholder benefit program. Eligible shareholders are those holding 100 shares or more; record dates are the end of September and end of March; benefits include a QUO card worth 2,500 yen per record date.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59367,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"general_ir","footnotes":""},"sector":[],"importance":[],"class_list":["post-107012","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n